Delivery Order SPE2DB22D1017-SPE2DB25FG5UV
Award Date
6/25/25
Potential Completion Date
6/26/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,368.99 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a prescription medication. The contract has an ultimate completion date of July 9, 2025 and is not set aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a $1,697.81 Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. The contract provides for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, to support federal government medical requirements. The contract has a period of performance through May 8, 2024 and was not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical...
This is a $14,134.77 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. The order has an ultimate completion date of December 21, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $33,611.28, is for the supply of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a pharmaceutical product, with a ceiling value of $3,330.74 and an ultimate completion date of May 22, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order awarded under an Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,213.11 firm fixed-price contract is to provide the drug YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 19, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $2,261.31 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a specialty medication. The award has a ceiling value of $4,112.90 and a performance period ending on March 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award is for the delivery of YUPELRI 175 MCG/3 ML SOLUTION UD 3ML, a specialty pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has a ceiling value of $5,954.24 and an ultimate completion date of December 17, 2024. It is a firm fixed-price delivery order...
This federal contract award is for the delivery of the pharmaceutical product YUPELRI 175 MCG/3 ML SOLUTION UD 3ML to the Defense Logistics Agency (DLA), a defense agency. The $4,524.45 firm-fixed-price contract has a period of performance through June 5, 2025 and was awarded on June 4, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This contract is not set aside and represents open competition....